Grab The Bull By The Horns And Subscribe To Our Free Newsletter Now!

OCFX Oxford City Football Penny Stock

Advertisement, see disclaimer below

Professional Soccer Play:

Oxford City Football

Undiscovered, overlooked company – what we
equate to an IPO on the OTC markets!

OXFC – Last Price = .027

April 15th, 2015:

Welcome trader! Today we are introducing an exciting IPO-style alert. This nickel priced company has a very short trading history, so the potential for being “before for the crowd” is greater than ever. We say “IPO-style” because this play is trading below everyone’s radar, and the time to get the word out is NOW.

In this report we are going to dig deep into OXFC’s financial reports, corporate insiders, and publicly-listed peers. We are happy to say that there is no previous history of awareness or promotion. We have laid out everything the company has stated in an easy-to-read package.

Our new top penny stock to watch is:

OXFC – Oxford City Football

Football in Europe is absolutely insane! The common term for the sport in America is Soccer – and that is what Oxford City Football (OXFC) represents – the holdings of a PROFESSIONAL soccer team playing in the “Conference North” of the England Football Conference.

Oxford City FC is a professional outdoor soccer team, which competes in the “Conference North” of the English Football Association under the name Oxford City Football Club. The team has been in existence for 132 years, being established in 1882. The Conference North, and its member clubs, are collectively able to compete for the prestigious English FA Cup, against some of the best English teams in the world for this championship trophy.

OXFC trades on the highest OTC tier, known as the OTCQB. Now is your chance to evaluate NICKEL-PRICED OXFC before anyone else.

The Company owns five (5) professional sports teams that are currently active and the rights to two (2) other expansion teams.

    1. Previously mentioned Oxford City Football Club is their top team, which competes in the “Conference North” of the English Football Association and has been in existence for 132 years.
    1. Oxford City Nomads is the Company’s 2nd professional outdoor soccer team, which competes in the “Hellenic Premier League” of the English Football Association under the name Oxford City Nomads.
    1. Oxford City Futsal is the Company’s 1st professional indoor soccer team, which competes in the “Futsal Premier League” of the English Futsal under the name Oxford City Futsal.
    1. Oxford City Major Arena Soccer League Franchise is the Company’s 1st professional team in the United States, which competes in the “MASL” under the name Oxford City. The MASL is the highest level of professional indoor soccer in North America, with teams from Mexico, Canada, and the US competing for the MASL Cup. The Company has also reserved the rights to additional home territories of Sioux Falls, South Dakota and South, Florida in the Major Arena Soccer League.
  1. Oxford City FC Basketball is the Company’s professional basketball team, which competes in the “EBL” of the English Basketball League under the name Oxford City Basketball.

Before we go over the company’s other assets lets take a quick look at their financial report.

The company doesn’t end their “year” on the last calendar day in December, instead OXFC’s fiscal year ends on June 30th, the middle of the year (the entire 12 months ending June 30th, 2014).

 

Year Ended June 30, 2014 Year Ended June 30, 2013
Revenues
$622,522
$53,435

 

OXFC makes money in five different ways. We dug up this information directly from their last annual report.

  • Executive Training Program revenue
  • Hourly rental of facilities
  • Admission to sporting events
  • Food and beverage revenue
  • Sponsorship revenue

We want you all to begin your research on OXFC and add it to the top of your watchlist IMMEDIATELY! Don’t forget how little trading history OXFC has. Once OXFC’s story begins to spread, prices may be in a different price channel.

Advertisement, see disclaimer below

Other Publicly Traded Futbol Teams:

Billions in “old money” sits within many professional soccer clubs. We are going to briefly take a look at other companies related to OXFC. You may have heard of several of these stock/teams/companies before.

These prices are from Bloomberg.com as of 4/15/15. We’ve also included the market capitalization for each.

OXFC Mega Public “Competitors”:

 

Ticker Company Name Stock Price Valuation
OXFC Oxford City Football (OTC) $0.027 $588 K
JUVE Juventus (FTSE/Italy) $0.34 $341 M
ASR AS Roma (FTSE/Italy) $0.58 $218 M
FCPP FC Porto (Portugal) $0.69 $10.4 M
AJAX AFC Ajax (Amsterdamn) $9.79 $170 M
MANU Manchester United (NYSE) $16.04 $2.6 B
CCP Celtic Football Club (London) $76.38 $71 M

 

Earlier we mentioned the five ways OXFC generates revenues. We found elaborate explanations in the company’s last 10-K Annual Report. Below is a summary of all of OXFC’s operations:

Ticket Sales – Oxford City FC in England, ticket sales have seen an increase from 2013 at $52,725 to $59,726 in 2014. All tickets can be purchased at Oxford City Stadium. Oxford City FC anticipates that this increase in ticket sales will continue as the Club challenges for promotion out of the English FA Conference North. Ticket prices for regular season home games during the 2014-2015 season are expected to range from $18.73 to $10.22 per game and the average ticket price is $14.47.

Oxford City FC of Texas has a contract with Ticketmaster, a national ticket outlet, for single game ticket sales other than ticket sold onsite at Fords Arena. Ticket prices for regular season home games during the 2014-2015 are expected to range from $10.00 to $15.00 per game and the average ticket price is $12.50.


Oxford City Stadium, England

Concessions The Company has the exclusive right to operate all Oxford City Stadium concessions, including private room and catering, and to receive all concession revenues. In Texas the Company has an agreement for use of Ford Arena and we do not receive any of the concession revenue. In both venues the Company keeps 100% of the merchandise sold.

Merchandise Sales. The Company offers team oriented clothing items and novelties online and at Oxford City Stadium and Ford Arena. At Oxford City Stadium and Ford Arena, the Company operates a full-service Team Shop that is open during games.

Local Television and Radio. Many Oxford City FC games are broadcast on local radio on BBC Radio. In 2014, there will be a total of 42 games in England. In Texas there will be 20 regular season games. OXFC expects to have a minimum of 3 games throughout the season to be televised for the 2014-2015 season.

Advertising and Corporate Sponsorship. The Company typically coordinates the sale of advertising with the sale of advertising at locations in both Oxford City Stadium in England and at Ford Arena in Texas, including space on the main scoreboard, ancillary scoreboards, outfield walls and concourse signage. Advertising is sold in game programs and on the Club’s Internet website. The Company also licenses the Club’s name and logo in connection with corporate sponsorships and promotions globally. The Company has increased the advertising and corporate sponsorship revenue significantly. It has increased to $48,419 in 2014, compared to $31,187 in 2013.

Rental Income of Venue. The revenue generated from Oxford City Stadium and the Oxford City 3G Training Facility has increased to $424,465 in 2014 from $338,607 in 2013. This rental income is expected to increase significantly in 2015.

In April 2015 the Company expects to initiate new ground improvements to Oxford City Stadium. A new 3G turf field is expected to increase rental income by at least 50% according to the Company’s projections. In addition the Company is planning to establish one of the largest indoor sports facility in all of Oxfordshire. This new facility will be the home to both Oxford City Futsal and Oxford City Basketball. The facility will also provide several additional fields, offices, and a restaurant that will increase the Company’s rental income.

Prize Money & Program Sales. In 2014 Oxford City FC earned $22,054 in prize money verse 2013’s $28,118 in prize money. Program sales were $6,302 in 2013 and 2014.

OXFC CEO (right) and Texas/CIT Uniform

Player Contracts and Salaries. Player salaries constitute the Club’s single largest item of expense. Both the English FA and the MASL require each team to enter into a uniform player contract with each of its players. Player contracts may be for single-year or multi-year terms. The Company is not obligated to continue to pay players under single-year or multi-year contracts if the player resigns, breeches team or organizational rules, or refuses to play.

As you can see, OXFC offers much more information than your typical pinksheet. It is not often we see this much info in a quarterly/annual report coming out of such a small company, so we are hopeful OXFC blooms into something special.

OXFC Quote Summary

 

Ticker OXFC
Price $0.027
Market Cap $588,000
Shares Outstanding 21.8M
Shares in Float 7.7M

 

Let’s take a minute to go over the CEO’s accomplishments.

Oxford City Football Club, Inc. is led by CEO Thomas Anthony Guerriero, a world-renowned value investor, published author, and diplomatic advisor on economic and fiscal policy. His background in business, higher education, and sports makes him equipped to create top-notch university programs. Not only is Guerriero a former professional soccer player, but he also has several degrees from top-tier universities. He holds a master’s degree from Harvard University, graduate certificates from Boston University and the University of Notre Dame, and bachelor degrees from Fairleigh Dickinson University and Thomas Edison State.

In business, Guerriero has established a reputation for being driven and having a strong work ethic. He was the youngest senior vice president at First Union in their 90-year history and worked as a CEO for both TAA and Global Wealth. While leading these companies, Guerriero also began writing books. He became a published author after writing “How to Understand and Master the Stock Market”, “How to Understand and Master Securities Laws & Regulations”, “Plan for Crisis”, and “Military Involvement and Trade Treaties: Exploring the Differences in Military Involvement of the United States in Foreign Countries, Post-Trade Treaty”.

After securing a wealth of experience in business, Guerriero decided to take his talents to the world of sports and acquire professional sports teams. This passion for sports led him to becoming the owner of an NBA D league team. In Guerriero’s first season as owner, the team won the Eastern Conference Championship for the first time in the biggest turn around in NBA D League history. This success made his vision even more clear. Guerriero decided to continue pursuing sports management with the intent to achieve something unique in professional sports and business. This was the seed that grew into Guerriero’s diversified holding company, OXFC.

2nd Revenue Stream: CIT University

The OXFC Academic Portfolio owns a diversified portfolio of academic institutions. OXFC owns CIT University in the US, which has designed and completed their first Master’s Degree Program in Sports Management, which they plan to partner with an accredited university to deliver the degree program globally online. The Company also owns Oxford City Sports College in Oxford England, which expects the strong ties in Oxford to strategically put the College in a tremendous position for the future.

CIT is anticipating to partner with some of the leading universities in the world.

CIT University has developed proprietary intellectual property in the field of higher education. The Master’s Program CIT developed will provide men and women the opportunity to earn their master’s degree in sports management and practically apply their knowledge and ideas in professional sports. CIT does not anticipate taking on students but rather enter into strategic partnerships with accredited universities in the near term to utilize our proprietary software, intellectual property, and programs.

The students who complete CIT programs at one of the partner universities will be given the opportunity to work with one of Oxford City’s professional sports teams with their research to get that first hand practical experience.

That wraps up our report on

OXFC: Oxford City Football

We want all members to continue their research right away. One look into OXFC’s trading history and you will see what we mean when we say “IPO-style”. We are literally the first to feast our eyes on this exciting OTCQB company. We are looking at everything as a whole and find it amazing that this company is at just .027 per share.

What are your thoughts? Have you considered OXFC yet?

Disclaimer:
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Owners of this newsletter may buy and sell shares at the open market at any time during this email program. Because of this conflict, individuals are strongly encouraged to not using this newsletter as the basis for any investment decision. We are not responsible for any losses you may incur while using this newsletter and its services. If you do not agree with this statement then please leave this service immediately. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.  We have been compensated four thousand dollars for this marketing awareness campaign on OXFC to take place 4/15/15 by a third party One22 Media LLC.
Read More

4/8/2015 Fast Moving Penny Stocks THCZ NTEK LIBE OSLH ECIGD

Hello Readers!
If you’re not a member of our email newsletter service make sure you subscribe today!

As always, we must start off with one of the day’s biggest movers, Totally Hemp Crazy Inc. (THCZ). So far today THCZ has traded over 13115431 shares, slightly below its 30 day average volume. The stock opened at 0.17 this morning, trading with a market cap of $34.47M. THCZ is now sitting at 0.17 as we type this. The latest press release from THCZ is: Totally Hemp Crazy Inc. Signs Distribution Agreement With Elk City, Oklahoma Dr Pepper Bottler. Investors will surely be watching THCZ over the next few days.

Another fast moving stock is NanoTech Entertainment, Inc. (NTEK). As we monitor NTEK, we’ve watched over 17252240 shares trade today, which is below its 30 day average volume. The stock is trading with a market cap of $9.42M. The last PR traders have seen from NTEK reads: NanoTech Signs Licensing Agreement with Paramount Pictures to Offer “”G.I. JOE: RETALIATION”” on UltraFlix 4K Streaming Network.                                                                                                                                                                                                                                      Liberated Energy, Inc. (LIBE) has also caught the attention of daytraders today. LIBE is currently trading at 0.01, which puts the company’s value at $1.00M. So far the stock has traded 7456775 shares, slightly higher than its 30 day average volume of 1976470.

Pull up the chart on OSLH and you will see why it deserves its spot in the media. Currently priced at about 0.01 per share, OSL Holdings Inc. (OSLH) has traded over 77541832 shares today, slightly below its 30 day average volume. The stock opened around 0.01 this morning. The latest press release from OSLH is OSL Holdings Announces Intent to Enter into a JV & Licensing Agreement with Cheryl Shuman. We will be sure to watch OSLH closely over the next week.

Lastly, we must take a look at what happened to Electronic Cigarettes International Group, Ltd. (ECIGD) today. ECIGD has traded over 4359966 shares today and is currently trading at 0.33. The stock opened around 0.29 this morning. Investors will surely be watching ECIGD closely over the next few  days.                                                                                                                                                                                                                  _______________________________________

Relevant Headlines:

Totally Hemp Crazy Inc. Signs Distribution Agreement With Elk City, Oklahoma Dr Pepper Bottler

NanoTech Signs Licensing Agreement with Paramount Pictures to Offer “G.I. JOE: RETALIATION” on UltraFlix 4K Streaming Network

Liberated Energy, Inc. Presents Shareholder Update

OSL Holdings Announces Intent to Enter into a JV & Licensing Agreement with Cheryl Shuman

Electronic Cigarettes International Group Reports Fourth Quarter and Full Year 2014 Financial Results

Again, make sure you subscribe to our free newsletter service today to get all the hot stock tips right to your inbox!

-MP

Read More

GBSN Stock Alert 3/27/15

Our new pick is GBSN – Great Basin Scientific

—————————————————————————————————————

Good Morning Readers And Welcome New Subscribers!

Great Basin Scientific, Inc., a molecular diagnostics company, develops and manufactures test kits and analyzers for a patented molecular diagnostic system used in single pathogen tests. The company provides a medical diagnostic test for the detection of Clostridium difficile, a gram-positive bacteria that causes diarrhea and other intestinal disorders. Its products under development comprise a diagnostic test for Group B streptococcus, a bacterium that colonizes in the warm moist areas of various humans, as well as a test for blood infections caused by Staphylococcus bacteria, a pre-surgical nasal screen for Staphylococcus aureus, and a food borne pathogen test. The company sells its diagnostic tests through a direct sales force in the United States, as well as through distributors in the European Union and New Zealand.

Enough with the boring stuff, let’s get to why we love GBSN.

GBSN has a super low float of just 2.16M shares and it shows!

Just last month GBSN had an incredible intraday run from 1.70 a share to 3.53 a share in one day!

That’s over 100% run intraday on a Nasdaq, that’s practically unheard of!

After that insane run GBSN is back trading under 2 bucks a share and we think this company could be due for another leg up!

Just a few days before this huge run GBSN announced that it had seen revenue growth of 50% for the 4 quarter and 111% for the full year!

For the fourth quarter of 2014, revenue was $445,283, an increase of 50.5% compared to $295,785 for the fourth quarter of 2013. For the 12 months ended December 31, 2014 revenue was $1,606,254, an increase of 111.2% compared to $760,646 for the 12 months ended December 31, 2013.”

Along with the financials, GBSN included some recent highlights for the company:

  • Filed a 510(k) pre-market application for the Company’s Group B Strep test in November of 2014
  • Initiated a clinical trial for the Company’s Staph ID/R panel in November of 2014
  • Initiated a clinical trial for the Company’s Shiga toxin producing E. coli(STEC) test in February of 2015

GBSN has all the ingredients to bring us a huge winner this morning:

  • Super low float of just 2.16M shares
  • Huge recent intraday run, settled back down
  • Revenue growth of 50% for the 4th quarter 2014 and 111% for the full year
  • Initiated clinical trials in Nov. 2014 and in Feb 2015 

Good luck!

-MP

Disclaimer:
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Owners of this newsletter may buy and sell shares at the open market at any time during this email program. Because of this conflict, individuals are strongly encouraged to not using this newsletter as the basis for any investment decision. We are not responsible for any losses you may incur while using this newsletter and its services. If you do not agree with this statement then please leave this service immediately. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Read More

PMCB FDA Penny Stock Alert

Our new pick is PMCB – Pharmacyte Biotech

—————————————————————————————————————

Good Morning Readers And Welcome New Subscribers!

PMCB is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R)

A new report was released yesterday with some great information.

“Biotech’s proprietary tech. may lead to new treatments for cancer”

“Perhaps the biggest potential breakthrough for PharmaCyte is the use of their Cell-in-a-Box technology on pancreatic cancer. PharmaCyte owns the exclusive worldwide rights to develop treatments for all types of solid cancerous tumors using its signature Cell-in-a-Box technology combined with low doses of the chemotherapy drug ifosfamide.

After being awarded the U.S. Food and Drug Administration’s (FDA) Orphan Drug designation, PharmaCyte can now take direct aim at becoming the treatment of choice for advanced pancreatic cancer. The ‘FDA Orphan Drug’ designation validates the technology and brings with it special assistance from the FDA in the development of the drug and up to seven additional years of marketing exclusivity in the U.S. if it makes it to market, in addition to possible exemptions or reductions in regulatory fees and taxes.

The fact that this company is trading for just over 10c a share and has FDA orphan drug designation is simply amazing to me.

 Here is the a link to the FDA showing proof of orphan drug designation

PharmaCyte will begin testing their solution head to head vs. head in the Stage 2b Clinical trials vs. the industry standard treatment (Which is Gemcitabine, sold under the brand name Gemzar(™) by Eli Lilly, combined with Celgene’s Abraxane).

Positive results would be a major development for the company and its investors.

With small cap biotech companies seeing some major activity recently, PMCB could be positioned to become the next major biotech winner.

A few examples of biotech runner we’ve seen are:

Oramed Pharmaceuticals (ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems. ORMP popped from $3.71 a share just a few days ago to a high of 8.25 in yesterday’s aftermarket sessions. That’s a 122% move!

Cytori Therapeutics, Inc. (CYTX), a late stage cell therapy company developing laboratory equipment and autologous cell therapies from adipose tissue to treat a variety of medical conditions, is another biotech leader. CYTX has been ramping up from around .45c a share a few weeks ago to a high of 1.47 a share. That’s a 226% jump!

Even in the OTC we have seen some nice activity. Just recently we witnessed one of the better known OTC pharma stocks triple (200% run) from .06 to .18 a share in just a few days!

Not only is the story great, but looking at the chart we really see very little downside here as this price range seems to be a level of huge support!

PMCB has virtually flatlined, trading within a few cent range for the past month. With share price still low, the market heating up, and PMCB starting to gather momentum, we really think we could be looking at the perfect opportunity to jump in before a potential breakout move!

-MP

Disclaimer:
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Owners of this newsletter may buy and sell shares at the open market at any time during this email program. Because of this conflict, individuals are strongly encouraged to not using this newsletter as the basis for any investment decision. We are not responsible for any losses you may incur while using this newsletter and its services. If you do not agree with this statement then please leave this service immediately. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.  We have been compensated two thousand dollars cash for this marketing awareness campaign on PMCB by a third party Initial Investments LLC to take place on 3/25/15 

 

Read More